Severity
Moderate
FDA Drug recall · Reported April 15, 2020
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
PharMEDium Services, LLC recalled fentaNYL Citrate Injection 50 mcg per mL, 100 mcg per 2 mL, 2 mL per syringe, For IV Use,… - a moderate-severity action.
fentaNYL Citrate Injection 50 mcg per mL, 100 mcg per 2 mL, 2 mL per syringe, For IV Use,… was recalled by PharMEDium Services, LLC in April 15, 2020. Reason: Firm is recalling 46 lots of various products because of a lack of sterility assurance.. Check the official notice for the remedy. Verify recall #D-1093-2020 with the FDA Drug before acting.
The recall
PharMEDium Services, LLC issued this moderate-severity FDA Drug recall-Firm is recalling 46 lots of various products because of a lack of sterility assurance..
Sourced from official FDA Drug enforcement records. Verify recall #D-1093-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1093-2020) was formally reported on April 15, 2020, with the manufacturer initiating the action on March 16, 2020. It is classified under Moderate severity (Class II), with a current status of Terminated. PharMEDium Services, LLC is listed as the recalling firm, operating out of Dayton, NJ. Federal records list the affected scope as 1350 units.
The documented reason for this recall is: Firm is recalling 46 lots of various products because of a lack of sterility assurance. Distribution data in the federal record shows the product reached: Distributed Nationwide in the US. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
1350 units
Related Recalls
6
5 from same agency
fentaNYL Citrate Injection 50 mcg per mL, 100 mcg per 2 mL, 2 mL per syringe, For IV Use, Rx Only, PharMEDium Services, LLC 913 N. Davis Ave Cleveland, MS 05810. NDC 61553-303-28
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-1093-2020 |
| Date reported | April 15, 2020 |
| Date initiated | March 16, 2020 |
| Recalling firm | PharMEDium Services, LLC |
| Firm location | Dayton, NJ |
| Affected scope | 1350 units |
| Distribution | Distributed Nationwide in the US |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported April 15, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.